GlassScriptPhysician profile
Ray W Shepherd
NPI 1639263940
$11,607.24
in general payments reported to CMS, 2019-2025
12 companies · $53.97 in 2025
The $53.97 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,679 · 2020: $939 · 2021: $51.43 · 2022: $1,123 · 2023: $383 · 2024: $378 · 2025: $53.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582 · Travel and Lodging: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.97 |
| Travel and Lodging | $232.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $8,800.00 | 2019-2020 | |
| Cook Medical LLC | $1,024.14 | 2019-2023 | Blue Rhino |
| Ethicon INC. | $972.43 | 2022 | |
| Intuitive Surgical, INC. | $270.38 | 2023-2024 | Da Vinci Surgical System |
| Pulmonx Corporation | $173.53 | 2021-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Steris Corporation | $157.66 | 2023 | |
| Galvanize Therapeutics, INC | $81.32 | 2024 | Aliya System |
| United Therapeutics Corporation | $53.97 | 2025 | |
| Olympus America INC. | $44.94 | 2023 | Spiration Valve System |
| Pinnacle Biologics, INC | $28.87 | 2023 | Photofrin |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.